Serum ace level
Pro Research Analysisby 
Searched over 200M research papers
Serum ACE Levels: Insights from Recent Research
Genetic Polymorphisms and Serum ACE Levels
Insertion/Deletion Polymorphism in ACE Gene
Research has shown that a significant portion of the variance in serum angiotensin-converting enzyme (ACE) levels can be attributed to genetic factors, particularly an insertion/deletion (I/D) polymorphism in the ACE gene. This polymorphism involves the presence or absence of a 250-bp DNA fragment and has been found to account for approximately 47% of the total phenotypic variance in serum ACE levels . Individuals with different ACE genotypes (II, ID, DD) exhibit markedly different serum ACE concentrations, with the highest levels observed in those with the DD genotype Rigat1990Biller2006.
Genotype-Corrected Reference Values
Given the significant impact of the ACE I/D polymorphism on serum ACE levels, it is recommended to use genotype-specific reference values for more accurate assessment. Studies have established that serum ACE levels are highest in individuals with the DD genotype and lowest in those with the II genotype, suggesting that genotype-corrected reference ranges can improve the sensitivity and specificity of ACE tests, particularly in the follow-up of conditions like sarcoidosis .
Serum ACE Levels in Disease States
Sarcoidosis
Elevated serum ACE levels are a hallmark of active sarcoidosis. Studies have consistently shown that patients with active sarcoidosis exhibit significantly higher serum ACE levels compared to healthy controls and patients with other chronic lung diseases Lieberman1975Brice1995Lieberman1976. This elevation is particularly useful for diagnosing and monitoring the disease, as serum ACE levels tend to normalize with effective corticosteroid therapy or disease resolution Lieberman1975Lieberman1976.
Other Lung Diseases
In contrast to sarcoidosis, serum ACE levels are generally reduced in patients with chronic obstructive lung disease (COPD), lung cancer, tuberculosis, and cystic fibrosis . However, elevated ACE levels have been observed in conditions like silicosis and miliary tuberculosis, which can sometimes complicate the differential diagnosis between these diseases and sarcoidosis Brice1995Szechiński1986.
Familial Elevation of Serum ACE
There are cases of familial clustering of elevated serum ACE levels, where individuals exhibit high ACE activity without the presence of conventional diseases associated with elevated ACE. This suggests a potential genetic predisposition to elevated serum ACE levels in certain families .
Serum ACE Levels in Special Populations
Pregnancy
Studies have shown that normal pregnancy does not significantly alter serum ACE levels. Measurements taken across different trimesters of pregnancy revealed no statistically significant differences, indicating that pregnancy does not impact serum ACE activity .
COVID-19
Recent research has explored the relationship between serum ACE2 levels and the severity of COVID-19. While no significant difference in ACE2 levels was found between COVID-19 patients and healthy controls, elevated ACE2 levels were associated with more severe disease outcomes, including ICU admission and mortality .
Conclusion
Serum ACE levels are influenced by genetic polymorphisms, particularly the ACE I/D polymorphism, and can vary significantly across different disease states. Elevated serum ACE is a key marker for active sarcoidosis and can aid in its diagnosis and management. However, it is important to consider genotype-specific reference values and the potential for familial elevation in certain cases. Understanding these nuances can enhance the clinical utility of serum ACE measurements in various medical contexts.
Sources and full results
Most relevant research papers on this topic